ENG/中
美国
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerGPT
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
抗疫概念
976.811
+21.954
2.30%
手動刷新
漲家數:
17
跌家數:
1
平家數:
- -
市盈率:
- -
高:
984.418
開:
954.770
低:
954.770
收:
954.857
資料載入中...
總覽
新聞資訊
【復星醫藥:控股子公司丁二酸復瑞替尼膠囊獲藥品註冊申請受理】金融界3月6日消息,復星醫藥控股子公司復星萬邦的丁二酸復瑞替尼膠囊藥品註冊申請近日獲國家藥品監督管理局受理。該新藥為創新型小分子化學藥物,擬用於治療非小細胞肺癌(ALK+)等,在ALK陽性的非小細胞肺癌晚期患者中展現出良好療效,截至2025年1月,集團為該新藥累計研發投入約4.39億元。2024年,中國境內用於治療非小細胞肺癌(ALK+)的主要藥品銷售額約31.64億元。該新藥商業化前尚需完成相關流程,上市後的銷售情況具有不確定性。
金融界
·
3小時前
京東健康:2024年實現總收入582億元 年度活躍用户數超1.83億
人民财讯
·
3小時前
京東健康(06618)2024年業績超市場預期 全年總收入582億元
智通财经网
·
4小時前
京東健康與京東集團簽署應收款項管理協議
财中社
·
4小時前
京東健康2024年全年總收入582億元,持續發力即時零售
新浪科技
·
4小時前
“銷量冠軍”還是“投訴之王”?比亞迪的雙面人生
Ofweek光电信息网
·
4小時前
京東健康(06618)2024年淨利同比增長94.31% 不派末期股息
金吾财讯
·
4小時前
白雲山:分公司收到阿託伐他汀鈣化學原料藥上市申請批准通知書
每日经济新闻
·
4小時前
白雲山(600332.SH):阿託伐他汀鈣化學原料藥上市申請獲批准
智通财经
·
4小時前
京東健康(06618)2024年股東應占盈利約41.62億元 同比增長94.31% 業務創新成果顯著
智通财经
·
4小時前
京東物流:2024年營收達1828億元,經調整後淨利潤同比增長186.8%
美港电讯
·
4小時前
《藍籌》京東健康(06618.HK)全年純利41.62億元人民幣升94.3%
阿斯达克财经
·
4小時前
京東健康(06618.HK):2024全年營收581.6億元人民幣,市場預估576.5億元人民幣。
美港电讯
·
4小時前
復星開心放手天元寵物接盤,萌寵賽道也是熱起來了 | 公司匯
标点财经
·
5小時前
港股三大指數午後漲幅擴大 恒指全日漲3.29% 快手(01024)升15.7%
金吾财讯
·
5小時前
四環醫藥03月06日獲主力加倉174萬元
市场透视
·
5小時前
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1515/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":976.81055,"timestamp":1741248510324,"preClose":954.8568,"halted":0,"volume":575283040,"delay":0,"changeRate":0.022992,"change":21.953735,"pbRate":1.681623,"amount":5623531621,"amplitude":0.03105,"prevYearClose":787.97723,"fiveDayClose":966.408,"twentyDayClose":851.934,"turnoverRate":0.007641,"marketCap":671721238880,"floatMarketCap":554131605088,"peRate":21.189191},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":984.418,"amplitude":0.03105,"preClose":954.8568,"low":954.7698,"pbRate":"1.681623","latestPrice":976.81055,"volume":575283040,"delay":0,"open":954.7698,"prevYearClose":787.97723,"prevWeekClose":904.791,"prevMonthClose":904.791,"prevQuarterClose":787.977,"fiveDayClose":966.408,"twentyDayClose":851.934,"sixtyDayClose":807.806,"secType":"PLATE","market":"HK","turnoverRate":0.007641,"peRate":21.189191,"marketCap":671721238880,"floatMarketCap":554131605088,"timestamp":1741248510324,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":17,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:16,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517132303","title":"【復星醫藥:控股子公司丁二酸復瑞替尼膠囊獲藥品註冊申請受理】金融界3月6日消息,復星醫藥控股子公司復星萬邦的丁二酸復瑞替尼膠囊藥品註冊申請近日獲國家藥品監督管理局受理。該新藥為創新型小分子化學藥物,擬用於治療非小細胞肺癌(ALK+)等,在ALK陽性的非小細胞肺癌晚期患者中展現出良好療效,截至2025年1月,集團為該新藥累計研發投入約4.39億元。2024年,中國境內用於治療非小細胞肺癌(ALK+)的主要藥品銷售額約31.64億元。該新藥商業化前尚需完成相關流程,上市後的銷售情況具有不確定性。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517132303","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517132303?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 17:56","pubTimestamp":1741254964,"startTime":"0","endTime":"0","summary":"金融界3月6日消息,复星医药控股子公司复星万邦的丁二酸复瑞替尼胶囊药品注册申请近日获国家药品监督管理局受理。该新药为创新型小分子化学药物,拟用于治疗非小细胞肺癌(ALK+)等,在ALK阳性的非小细胞肺癌晚期患者中展现出良好疗效,截至2025年1月,集团为该新药累计研发投入约4.39亿元。2024年,中国境内用于治疗非小细胞肺癌(ALK+)的主要药品销售额约31.64亿元。该新药商业化前尚需完成相关流程,上市后的销售情况具有不确定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06175648566599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0096","BK0239","BK1593","BK0175","BK4008","BK0187","BK0183","BK0060","BK0028","BK1515","BK0012","02196","BK0188","BK0196","BK4585","BK1191","600196","BK4500","ALK","BK4588"],"gpt_icon":0},{"id":"2517323521","title":"京東健康:2024年實現總收入582億元 年度活躍用户數超1.83億","url":"https://stock-news.laohu8.com/highlight/detail?id=2517323521","media":"人民财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517323521?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 17:49","pubTimestamp":1741254571,"startTime":"0","endTime":"0","summary":"人民财讯3月6日电,3月6日,京东健康发布财报显示,2024年,京东健康总收入达582亿元,非国际财务报告准则指标下(Non-IFRS)净利润达47.9亿元。截至2024年12月31日,京东健康过去12个月的年度活跃用户数量超1.83亿;第三方合作商家数量超过10万家,平台生态持续向好;京东互联网医院日均在线问诊咨询量已超49万。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503063338625949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1142","BK1571","LU0051755006.USD","86618","BK1247","BK1589","BK1591","06618","BK1583","LU0456827905.SGD","BK1515"],"gpt_icon":0},{"id":"2517134466","title":"京東健康(06618)2024年業績超市場預期 全年總收入582億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517134466","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517134466?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 17:37","pubTimestamp":1741253831,"startTime":"0","endTime":"0","summary":"京东健康公布2024年全年业绩 率先实现医疗大模型规模化全场景落地","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20250306/20250306173842_49212.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250306/20250306173842_49212.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258606.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1571","BK1591","BK1583","BK1589","LU0456827905.SGD","BK1515","BK1142","06618","LU0051755006.USD","86618","BK1247"],"gpt_icon":0},{"id":"2517213443","title":"京東健康與京東集團簽署應收款項管理協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2517213443","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517213443?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 17:32","pubTimestamp":1741253560,"startTime":"0","endTime":"0","summary":"3月6日,京东健康(06618/86618)发布公告,2025年3月6日,公司与京东集团签订了应收款项管理框架协议,京东集团将为公司提供应收款项管理服务,服务期限为三年,至2027年12月31日止。根据协议,京东集团将购买公司线上零售业务产生的消费信贷应收款项,价格为应收款项的账面价值,且不收取额外服务费。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503063338608515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4503","IE0008368742.USD","LU1688375341.USD","BK1571","BK4220","BK4585","LU1188198961.HKD","LU0051755006.USD","BK1142","BK4505","LU0456827905.SGD","86618","BK4526","BK4524","IE00BGV7N243.SGD","BK1591","BK4509","09618","BK1589","LU0106959298.USD","BK4504","BK4531","SG9999002463.SGD","LU0326950275.SGD","LU0463099449.HKD","BK1583","BK4579","BK1515","LU0588546209.SGD","06618","BK4122","LU0244354667.USD","BK4551","JD","LU0307460666.USD","LU1880383366.USD","BK4558","BK1247","BK4588"],"gpt_icon":0},{"id":"2517881137","title":"京東健康2024年全年總收入582億元,持續發力即時零售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517881137","media":"新浪科技","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517881137?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 17:32","pubTimestamp":1741253520,"startTime":"0","endTime":"0","summary":"新浪科技讯 3月6日下午消息,京东健康 发布2024年全年业绩公告。公告显示,京东健康2024年总收入为人民币582亿元,非国际财务报告准则指标下净利润达47.9亿元,收入和净利润均超过市场预期。 此外,京东健康在北京市新开设多家京东大药房新型门店,打造了全新的零售药房消费和服务体验;还在北京市海淀区上线了首个京东买药自助售(取)药机,更高效快捷地满足本地居民用药需求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/2025-03-06/doc-inenthxf6663100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1247","06618","BK1571","LU0456827905.SGD","BK1142","LU0051755006.USD","BK1591","BK1515","BK1583","BK1589","86618"],"gpt_icon":0},{"id":"2517813447","title":"“銷量冠軍”還是“投訴之王”?比亞迪的雙面人生","url":"https://stock-news.laohu8.com/highlight/detail?id=2517813447","media":"Ofweek光电信息网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517813447?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 17:27","pubTimestamp":1741253220,"startTime":"0","endTime":"0","summary":"从2023年销量突破300万辆,到2024年直接飙升至427万辆,比亚迪的增速令人咋舌。然而,销量的狂飙突进并没有让比亚迪远离争议。根据车质网的数据,2024年投诉量前十的车型中,比亚迪独占六席。02质量问题频发除了价格问题,比亚迪的车型还被曝出多项质量问题。比亚迪的销量神话无疑令人瞩目,但投诉量的激增也为其敲响了警钟。销量与投诉量的“双冠王”地位,既是对比亚迪实力的肯定,也是对其未来发展的考验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306173945989e66d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306173945989e66d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2249611893.SGD","002594","01211","BK1522","LU0359202008.SGD","LU0588546209.SGD","HYDD.SI","SG9999015978.USD","BYDDY","LU2097828557.USD","LU0417516738.SGD","BK1515","SG9999002463.SGD","LU0348767384.USD","00285","LU0274383008.USD","LU0214875030.USD","LU1868837565.USD","LU1023057109.AUD","LU0289739343.SGD","SG9999015945.SGD","LU0289961442.SGD","BK1607","LU1242518931.SGD","LU0359201612.USD","SG9999015986.USD","LU2097828474.EUR","BK1610","LU0052750758.USD","IE00BD6J9T35.USD","LU0819123356.HKD","LU0593848301.USD","LU0211977185.USD","LU2360107325.USD","LU0516422366.SGD","LU0449515922.USD","LU2348774022.SGD","LU0516422440.USD","BK1119","SG9999006514.SGD","LU1242518857.USD","LU0143863784.USD","LU0348766576.USD","LU0175139822.USD","LU0511384066.AUD","LU1868838027.USD","LU0516423091.SGD","LU0164872284.USD","81211","LU0054450605.USD"],"gpt_icon":1},{"id":"2517131145","title":"京東健康(06618)2024年淨利同比增長94.31% 不派末期股息","url":"https://stock-news.laohu8.com/highlight/detail?id=2517131145","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517131145?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 17:19","pubTimestamp":1741252795,"startTime":"0","endTime":"0","summary":"金吾财讯 | 京东健康 公布,截至2024年12月31日止年度的年度业绩。期内,归属于公司所有者年度盈利41.62亿元,同比增长94.31%;每股基本盈利1.32元,去年同期为0.69元。期内,公司收入581.6亿元,同比增长8.65%。公告指,总收入的增长主要是由于销售医药和健康产品所得商品收入增加6.9%至2024年的488亿元。线上平台、数字化营销及其他服务所得服务收入增加18.9%至2024年的94亿元。期内,毛利为133亿元,毛利率为22.9%,去年同期毛利率为为22.2%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ZmY0OWUwYjc0ZDYzZDFkYzRkNWJlMTY3NjE5MjUxNjU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZmY0OWUwYjc0ZDYzZDFkYzRkNWJlMTY3NjE5MjUxNjU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954529","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1571","LU0051755006.USD","BK1142","BK1589","BK1583","BK1591","LU0456827905.SGD","BK1247","86618","06618"],"gpt_icon":0},{"id":"2517131106","title":"白雲山:分公司收到阿託伐他汀鈣化學原料藥上市申請批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2517131106","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517131106?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 17:18","pubTimestamp":1741252718,"startTime":"0","endTime":"0","summary":"每经AI快讯,3月6日,白云山(600332.SH)公告称,公司分公司白云山化学制药厂收到国家药监局签发的阿托伐他汀钙《化学原料药上市申请批准通知书》。阿托伐他汀钙为HMG-CoA还原酶抑制剂,主要用于治疗高胆固醇血症等。该原料药的获批,有助于丰富白云山化学制药厂心脑血管类产品的种类,但对公司当期业绩无重大影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503063338598582.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503063338598582.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","00874","BK1191","BK1521","BK1197","BK1606"],"gpt_icon":0},{"id":"2517139065","title":"白雲山(600332.SH):阿託伐他汀鈣化學原料藥上市申請獲批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2517139065","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517139065?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 17:18","pubTimestamp":1741252682,"startTime":"0","endTime":"0","summary":"智通财经APP讯,白云山(600332.SH)公告,公司分公司广州白云山医药集团股份有限公司白云山化学制药厂(简称“白云山化学制药厂”)收到国家药品监督管理局签发的阿托伐他汀钙《化学原料药上市申请批准通知书》。公告显示,阿托伐他汀钙为羟甲基戊二酰辅酶A(HMG-CoA)还原酶抑制剂。主要通过抑制HMGCoA还原酶的合成,从而抑制体内胆固醇的合成,降低血清低密度脂蛋白胆固醇、甘油三酯的含量。主要适应症为原发性高胆固醇血症、混合型高脂血症、高甘油三酯血症、纯合子家族性高胆固醇血症及防治动脉粥样硬化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258586.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00874","BK0097","BK1197","BK1521","BK1606","BK1515","600332","BK0070","BK0028","BK0188","BK0196","BK0239","BK0175","BK0012","BK0183","BK0096"],"gpt_icon":0},{"id":"2517390571","title":"京東健康(06618)2024年股東應占盈利約41.62億元 同比增長94.31% 業務創新成果顯著","url":"https://stock-news.laohu8.com/highlight/detail?id=2517390571","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517390571?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 17:14","pubTimestamp":1741252452,"startTime":"0","endTime":"0","summary":"智通财经APP讯,京东健康 公布2024年业绩,收入约581.6亿元,同比增长8.6%;毛利约133.086亿元,同比增长12.2%;公司所有者应占盈利约41.62亿元,同比增长94.31%;每股盈利1.32元。公告称,总收入的增长主要是由于销售医药和健康产品所得商品收入由2023年的人民币457亿元增加6.9%至2024 年的人民币488亿元。线上平台、数字化营销及其他服务所得服务收入由2023年的人民币79亿元增加18.9%至 2024年的人民币94亿元。京东健康持续强化自营优势,提升在线平台和即时零售业务竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1142","BK1571","LU0051755006.USD","86618","BK1247","BK1589","BK1591","06618","BK1583","LU0456827905.SGD","BK1515"],"gpt_icon":0},{"id":"2517139343","title":"京東物流:2024年營收達1828億元,經調整後淨利潤同比增長186.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517139343","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517139343?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 17:09","pubTimestamp":1741252183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["06618","BK1515","BK1587","BK1583","BK1151","LU0051755006.USD","BK1604","BK1571","BK1589","BK1541","BK1591","BK1247","BK1142","02618","86618","LU0456827905.SGD","BK1502"],"gpt_icon":0},{"id":"2517139074","title":"《藍籌》京東健康(06618.HK)全年純利41.62億元人民幣升94.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517139074","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517139074?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 17:06","pubTimestamp":1741251960,"startTime":"0","endTime":"0","summary":"京东健康(06618.HK) 公布截至去年12月底止全年业绩,营业额581.6亿元人民币(下同),按年升8.6%。纯利41.62亿元,按年升94.3%;每股盈利1.32元。不派息。非国际财务报告准则经营盈利按年增4.9%至25.99亿元;年度非国际财务报告准则盈利升15.9%至47.92亿元。截至去年12月31日,年度活跃用户数量达到1.84亿,去年全年日均在线问诊咨询量超过49万。(sl/u)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-06 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240924144113511_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240924144113511_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1422741/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1247","BK1571","LU0456827905.SGD","LU0051755006.USD","BK1142","BK1591","BK1515","86618","BK1583","BK1589","06618"],"gpt_icon":0},{"id":"2517136300","title":"京東健康(06618.HK):2024全年營收581.6億元人民幣,市場預估576.5億元人民幣。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517136300","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517136300?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 17:01","pubTimestamp":1741251705,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1515","BK1583","LU0456827905.SGD","BK1247","BK1591","86618","06618","BK1142","BK1571","LU0051755006.USD","BK1589"],"gpt_icon":0},{"id":"2517136808","title":"復星開心放手天元寵物接盤,萌寵賽道也是熱起來了 | 公司匯","url":"https://stock-news.laohu8.com/highlight/detail?id=2517136808","media":"标点财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517136808?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 16:26","pubTimestamp":1741249560,"startTime":"0","endTime":"0","summary":"拟收购淘通科技天元宠物此次交易方案预计在3月17日前披露,若逾期未完成,将复牌并终止筹划相关事项,并承诺1个月内不再筹划重大资产重组事项。目前,公司已与上述四方签署收购意向协议,约定公司拟收购淘通科技的控股权,最终价格以评估机构出具的报告为参考依据,经各方协商约定。但若剔除非经常性损益影响,天元宠物的归母净利润仍下滑逾14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306165234989e598d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306165234989e598d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","600196","02196","BK1593"],"gpt_icon":0},{"id":"2517387531","title":"港股三大指數午後漲幅擴大 恒指全日漲3.29% 快手(01024)升15.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517387531","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517387531?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 16:18","pubTimestamp":1741249088,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股三大指数午后涨幅扩大,全日高开高走,截至收盘,恒指涨3.29%,国企指数涨3.57%,恒生科技指数涨5.40%。浦银国际发研报指,今年1月下旬以来,DeepSeek的关注度迅速提升。该行续指,中国互联网龙头加强AI的战略地位,提升AI的资本开支并有望较此前翻倍。该行表示,DeepSeek的创新有望缓解美对中在半导体,尤其是AI算力的限制所带来的压力。个股方面,蜜雪集团涨14.95%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/MTYwMGM1ZDEwYjRjZDY4ZmI3MTk0ZDEyM2Y1MWFkMjMxODA4Mzk0Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MTYwMGM1ZDEwYjRjZDY4ZmI3MTk0ZDEyM2Y1MWFkMjMxODA4Mzk0Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d98b2609bc10558b50734bda5cfc045c","theme_name":"🔥熱榜No.2 · 恆生指數和恆生科技指數創收盤新高","theme_type":2,"isJumpTheme":false,"source_url":"1954523","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HHImain","LU0868486357.SGD","00669","00001","LU0348767384.USD","HSCEI","00881","LU0149721374.USD","LU2097828631.EUR","BK1608","00285","LU1481107354.HKD","HSI","LU0164880469.USD","00836","LU2097828714.EUR","LU0106259558.USD","01024","HSTECH","MHImain","LU0572944931.SGD","BK1515","HSImain","SG9999011746.SGD","BK1591","MCHmain","LU0828237510.HKD","LU0164865239.USD","LU1794554557.SGD","YANG","LU1251922891.USD","BK1520","89618","IE0008368411.USD","IE0009570106.USD","81024","LU1808992512.USD","LU2097828805.USD","LU1282649067.USD","LU0048580855.USD","02833","513600","LU0227179875.USD","LU0865486749.SGD","LU0029875118.USD","BK1249","LU0072462343.USD"],"gpt_icon":1},{"id":"2517813618","title":"四環醫藥03月06日獲主力加倉174萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517813618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517813618?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 16:17","pubTimestamp":1741249068,"startTime":"0","endTime":"0","summary":"03月06日, 四环医药股价涨3.33%,报收0.62元,成交金额1608万元,换手率0.28%,振幅3.33%,量比1.66。四环医药今日主力资金净流入174万元,连续3日净流入,上一交易日主力净流入90万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为60.00%,平均涨幅为4.76%。该股近5个交易日下跌1.59%,主力资金累计净流出485万元;近20日主力资金累计净流入544万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170535a2622e98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170535a2622e98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1600","BK1515","BK1593","00460"],"gpt_icon":0}],"pageSize":16,"totalPage":37,"pageCount":2,"totalSize":579}]}}